PLx Pharma stock drops again, and company looks to clarify USPTF’s recent comments about aspirin use

Shares of PLx Pharma Inc.
PLXP,
-9.01%
dropped 9.2% in afternoon trading Thursday, but nearly halved their earlier loss, as the drug maker responded to recently raised concerns over the use of aspirin to prevent heart attacks. The stock was down as much…

Click here to view the original article.